Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
复制标题
DOI:
10.1371/journal.pone.0029074
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Sakuraba H
中科院分区:
文献类型:
--
作者:
Kodama T;Togawa T;Tsukimura T;Kawashima I;Matsuoka K;Kitakaze K;Tsuji D;Itoh K;Ishida Y;Suzuki M;Suzuki T;Sakuraba H
To find a new biomarker of Tay-Sachs disease and Sandhoff disease. The lyso-GM2 ganglioside (lyso-GM2) levels in the brain and plasma in Sandhoff mice were measured by means of high performance liquid chromatography and the effect of a modified hexosaminidase (Hex) B exhibiting Hex A-like activity was examined. Then, the lyso-GM2 concentrations in human plasma samples were determined. The lyso-GM2 levels in the brain and plasma in Sandhoff mice were apparently increased compared with those in wild-type mice, and they decreased on intracerebroventricular administration of the modified Hex B. The lyso-GM2 levels in plasma of patients with Tay-Sachs disease and Sandhoff disease were increased, and the increase in lyso-GM2 was associated with a decrease in Hex A activity. Lyso-GM2 is expected to be a potential biomarker of Tay-Sachs disease and Sandhoff disease.
登录
查看更多内容
DOI:
10.1515/bchm3.1986.367.1.241
发表时间:
1986-03-01
期刊:
BIOLOGICAL CHEMISTRY HOPPE-SEYLER
影响因子:
--
作者:
NEUENHOFER, S;CONZELMANN, E;SANDHOFF, K
通讯作者:
SANDHOFF, K
影响因子:
3.5
作者:
Huang, JQ;Trasler, JM;Gravel, RA
通讯作者:
Gravel, RA
DOI:
10.1038/mt.2011.27
发表时间:
2011-06
期刊:
Molecular therapy : the journal of the American Society of Gene Therapy
影响因子:
--
作者:
通讯作者:
--
影响因子:
11.2
作者:
KOBAYASHI, T;GOTO, I;SUZUKI, K
通讯作者:
SUZUKI, K
DOI:
10.1016/0005-2760(91)90021-9
发表时间:
1991-01-28
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA
影响因子:
--
作者:
KOBAYASHI, T;GOTO, I
通讯作者:
GOTO, I